18-40 GHz High Frequency Power Amplifier

The U.S. Food and Drug Administration’s Office of Acquisition and Grant Services is seeking a Firm-Fixed-Price contract for a single 18-40 GHz High Frequency Power Amplifier under solicitation 75F40126Q133599, issued as a combined synopsis and solicitation for commercial items. This procurement is a Total Small Business Set-Aside under FAR 19.5, limited to small businesses registered in SAM.gov with a Unique Entity Identifier and certified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a size standard of 1,000 employees. The amplifier must be a standalone solid-state unit with integrated control/programming interface, power supply, and cooling system, powered by standard 120 V single-phase mains, delivering a minimum output power of 20 W, a small signal gain of at least 43 dB, and capable of amplifying both continuous wave and modulated signals. Remote control via USB or Ethernet is required, alongside a front panel interface. The contract includes optional items: two 2.92 mm phase-stable cable assemblies and one 2.92 mm waveguide-to-coaxial adapter. All equipment must be delivered FOB destination to the FDA Center for Devices and Radiological Health in Silver Spring, Maryland, with shipping, handling, and delivery charges included in the quoted price, and delivery must avoid federal holidays. Prices must remain firm through September 30, 2026, and the item must be backed by a minimum one-year warranty from the date of acceptance. The award will be made using a Lowest Price Technically Acceptable (LPTA) methodology, where the lowest-priced offer that meets all technical requirements will be selected, with technical acceptability serving as a mandatory pass/fail gate. All proposals must be submitted electronically via email to Howard Nesmith by June 18, 2026, at 1:00 PM Central Time, referencing the solicitation number, and must include full technical documentation to demonstrate compliance with each specification. Offerors must comply fully with Section 508 accessibility standards, submitting an Accessibility Conformance Report (ACR) or HHS checklist, and must remediate any non-conforming products at their own expense. The contract mandates adherence to the Buy American Act and Executive Order 14005, and requires compliance with multiple FAR and HHSAR clauses, including whistleblower protections,